The eBioNews Team sincerely invites you to visit our newly released 
beta-version site at: www.ebionews.com. This is a news and resource information 
center dedicated to promoting R&D and commercialization in life sciences and 
bio-economy. The website presents the information that is knowledge-rich, 
useful, and beneficial to our readers. Generally, eBioNews information is 
organized into the following two clusters:
        News Center         Resource Center 
Headlines 
Research Frontiers     
General Researches      
Clinical Development  
Enterprise & Industry  
Products & Services   
Investment & Financials         
Features          
Newsletters       
eBioResources           
Cooperation    
Events 
Human Resources                  
Intellectual Property 
Finance & Legal          
Operations      
Organizations    
Publications 

The News Center provides selected and enriched news, information, data, and 
knowledge in life science researches and business.  Particularly, the 
cutting-edges and significant achievements of life science researches, such as 
stem cells, cancer research, biomarker, nanotechnology, microRNA and 
personalized medicine, etc, are reported timely.  The Resource Center is a 
system that hosts and facilitates the resources-related information between and 
among multiple parties, especially for promoting communication, networking, 
cooperation, collaboration, consortium, partnering, joint venture, licensing, 
out-sourcing, and trading. 
Readers' needs and satisfaction are our top priority. We would like to make 
your surfing and reading in eBioNews an enjoyable experience. If you have 
suggestions and comments on our website, please feel free to contact us via 
email at supp...@ebiomail.com. We will do our best in addressing your points 
and further developing the website.
Your feedback and input are deeply appreciated. Thank you for your support for 
the construction and development of the eBioNews. 
This message was sent by eBioCenter Corporatioin. You can choose not to receive 
further mailings by forwarding this message to remov...@ebiocenter.com.  

Reply via email to